Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
DSM, Sinochem Seal Antibiotics Deal
by Michael McCoy
September 5, 2011
| A version of this story appeared in
Volume 89, Issue 36
DSM and Sinochem have completed a 50-50 joint venture that will own DSM’s anti-infectives business, one of the world’s largest manufacturers of penicillin and other antibiotics. Under the agreement, first announced in December 2010, Sinochem paid about $300 million for its 50% stake in the business, which has annual sales of roughly $425 million and about 2,000 employees. It will be named DSM Sinochem Pharmaceuticals and will have headquarters in Hong Kong.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X